Skip to search formSkip to main contentSkip to account menu

Baraclude

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

entecavir
entecavir 0.5 MG Oral Tablet [Baraclude]entecavir Oral Tablet [Baraclude]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A Combination anti-HBV regimen using lamivudine and other agents in treatment of resistant chronic hepatitis B
Background:    Several  difficulties  remain in formulating treatment  for   chronic    hepatitis  B  (CHB), 350  million… 
Review
2007
Review
2007
[Pharmacological properties and clinical efficacy of entecavir monohydrate (Baraclude Tablet 0.5 mg), an anti-HBV drug].
  • M. AmanoArata Goto
  • Nihon yakurigaku zasshi. Folia pharmacologica…
  • 2007
  • Corpus ID: 20171504
2007
2007
Entacavir (Baraclude) Gets Boxed Warning About HIV Resistance
ROCKVILLE, Md. -- The FDA has added a boxed warning to the litany of cautions about the use of entacavir (Baraclude), a hepatitis… 
2007
2007
Use of Baraclude [entecavir] is not recommended in patients with HIV/hepatitis B coinfection who are not receiving HAART
  • 2007
  • Corpus ID: 195168178
2006
2006
Therapy using baraclude and hepatic artery chemoembolization(TACE)is helpful to prolong the survival for paitents with hepatocellular carcinoma(HCC)with coexisting active hepatitis B
Objective To observe the effect of therapy using baraclude and TACE on the liver biochemistry and survival for paitents with HCC…